Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $573 Billion
  • Q3 2025

Decheng Capital LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $573 Billion distributed in 23 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $257B, Nuvation Bio Inc. with a value of $96B, Upstream Bio Inc. with a value of $61.8B, Aardvark Therapeutics Inc with a value of $52.1B, and Newamsterdam Pharma CO Nv Shs with a value of $18.7B.

Examining the 13F form we can see an increase of $177B in the current position value, from $396B to 573B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $573 Billion
Healthcare: $182 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cg Oncology Inc
-
$257 Billion 44.78% of portfolio
-
Q4 2024 Added 16.3%
$1.06B
$96 Billion 16.75% of portfolio
25,954,439
Q3 2024 Added 273.43%
Upstream Bio Inc.
-
$61.8 Billion 10.78% of portfolio
-
Q4 2024 New
Aardvark Therapeutics Inc
-
$52.1 Billion 9.08% of portfolio
-
Q1 2025 New
-
$18.7 Billion 3.26% of portfolio
-
Q3 2025 Reduced 14.67%
$4.4B
$17.6 Billion 3.06% of portfolio
186,546
Q3 2025 Reduced 1.35%
$5.94B
$9.81 Billion 1.71% of portfolio
210,000
Q3 2025 Reduced 7.08%
$4.2B
$9.67 Billion 1.69% of portfolio
595,466
Q2 2025 Reduced 95.0%
$83.3M
$7.76 Billion 1.35% of portfolio
4,286,104
Q3 2025 Reduced 5.41%
$168M
$7.68 Billion 1.34% of portfolio
4,041,736
Q1 2025 Added 78.31%
$1.45B
$7.45 Billion 1.3% of portfolio
547,609
Q3 2025 Added 242.26%
$35M
$6.36 Billion 1.11% of portfolio
4,447,308
Q4 2023 New
$2.34B
$5.96 Billion 1.04% of portfolio
143,000
Q2 2025 Reduced 19.64%
$5.29B
$5.7 Billion 0.99% of portfolio
32,300
Q3 2025 Reduced 51.06%
$162M
$3.19 Billion 0.56% of portfolio
515,555
Q4 2023 New
$75.8M
$2 Billion 0.35% of portfolio
1,323,327
Q2 2025 Reduced 34.48%
$351M
$806 Million 0.14% of portfolio
92,748
Q3 2025 Reduced 61.28%
$19B
$758 Million 0.13% of portfolio
7,979
Q2 2025 Reduced 32.09%
$158M
$726 Million 0.13% of portfolio
326,810
Q4 2023 New
Grail Inc
-
$573 Million 0.1% of portfolio
-
Q3 2024 Reduced 46.58%
$385M
$563 Million 0.1% of portfolio
59,900
Q2 2025 New
-
$115 Million 0.02% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 23
  • Current Value $573 Billion
  • Prior Value $396 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email